An open-label, single-arm, phase 2 (PX-171-004) study of single-agent carfilzomib in bortezomib-naive patients with relapsed and/or refractory multiple myeloma (Q34008600)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | An open-label, single-arm, phase 2 (PX-171-004) study of single-agent carfilzomib in bortezomib-naive patients with relapsed and/or refractory multiple myeloma |
scientific article |
Statements
1 reference
An open-label, single-arm, phase 2 (PX-171-004) study of single-agent carfilzomib in bortezomib-naive patients with relapsed and/or refractory multiple myeloma (English)
1 reference
Sagar Lonial
1 reference
Robert Z Orlowski
1 reference
Andrzej J Jakubowiak
1 reference
Ravi Vij
1 reference
Michael Wang
1 reference
Jonathan L Kaufman
1 reference
A Keith Stewart
1 reference
Vishal Kukreti
1 reference
Sundar Jagannath
1 reference
Kevin T McDonagh
1 reference
Melissa Alsina
1 reference
Nizar J Bahlis
1 reference
Frederic J Reu
1 reference
Nashat Y Gabrail
1 reference
Andrew Belch
1 reference
Jeffrey V Matous
1 reference
Peter Lee
1 reference
Peter Rosen
1 reference
Michael Sebag
1 reference
David H Vesole
1 reference
Lori A Kunkel
1 reference
Sandra M Wear
1 reference
Alvin F Wong
1 reference
David S Siegel
1 reference
3 May 2012
1 reference
1 reference
119
1 reference
24
1 reference
5661-5670
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference